CD14; lymphocyte antigen 96 (LY96; MD2)

In vitro and in vivo studies suggest that palmitoyl-oleoyl-phosphatidylglycerol (POPG) could help prevent or treat RSV infection.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149062/
http://dx.doi.org/10.1038/scibx.2010.90
_version_ 1783520733093167104
collection PubMed
description In vitro and in vivo studies suggest that palmitoyl-oleoyl-phosphatidylglycerol (POPG) could help prevent or treat RSV infection.
format Online
Article
Text
id pubmed-7149062
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-71490622020-04-13 CD14; lymphocyte antigen 96 (LY96; MD2) Science-Business eXchange Article In vitro and in vivo studies suggest that palmitoyl-oleoyl-phosphatidylglycerol (POPG) could help prevent or treat RSV infection. Nature Publishing Group US 2010 /pmc/articles/PMC7149062/ http://dx.doi.org/10.1038/scibx.2010.90 Text en © Nature Publishing Group 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
CD14; lymphocyte antigen 96 (LY96; MD2)
title CD14; lymphocyte antigen 96 (LY96; MD2)
title_full CD14; lymphocyte antigen 96 (LY96; MD2)
title_fullStr CD14; lymphocyte antigen 96 (LY96; MD2)
title_full_unstemmed CD14; lymphocyte antigen 96 (LY96; MD2)
title_short CD14; lymphocyte antigen 96 (LY96; MD2)
title_sort cd14; lymphocyte antigen 96 (ly96; md2)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149062/
http://dx.doi.org/10.1038/scibx.2010.90

Ejemplares similares